Abstract

Dr. Faber provided support for a valuable methodology for the comparison of mass spectra. However, since many other factors are involved in the evaluation process before declaring a sample “positive”, i.e. reporting an adverse analytical finding, his conclusions on this subject are incorrect. In this paper a number of arguments are listed showing that Dr. Faber did not take all factors under consideration when making his claims. These factors involve parameters directly related to mass spectrometric criteria, but also to other equally important factors including sample preparation specificity, retention time (since in doping control mass spectrometry is used as part of a hyphenated technique), etc. These arguments clearly illustrate that the risks for a false positive declaration can not be calculated according to Dr. Faber’s proposed methodology.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.